Clinical Study
Somatosensory and Pharyngolaryngeal Auras in Temporal Lobe Epilepsy Surgeries
Table 3
Baseline characteristics of patients in the SSA/PVSA group and controls.
| | Variable | SSA/PVSA ( = 11) | Controls ( = 147) | -value |
| | Demographic | | | | | Female sex | 8 (72.7%) | 66 (44.9%) | 0.095 | | Age at surgery (yrs) | 40.18 | 33.44 | 0.049 | | Duration of epilepsy (yrs) | 26.91 | 20.84 | 0.086 | | Seizure characteristics | | | | | Daily seizures or worse | 2 (18.2%) | 38 (25.9%) | 0.649 | | Early ictal symptoms suggestive of insular involvement | | | | | Epigastric symptoms | 6 (54.5%) | 54 (36.7%) | 0.280 | | Motor symptoms | 4 (36.4%) | 16 (10.9%) | 0.022 | | Auditory symptoms | 0 (0%) | 7 (4.8%) | 1.000 | | Cephalic symptoms | 1 (9.1%) | 27 (18.4%) | 0.572 | | Dysphasic symptoms | 0 (0%) | 7 (4.8%) | 1.000 | | Generalized seizures | 7 (63.6%) | 94 (63.9%) | 1.000 | | Status epilepticus | 1 (9.1%) | 6 (4.1%) | 0.296 | | Number of AEDs tried | 5.00 | 4.36 ( = 144) | 0.280 | | Left side | 5 (45.5%) | 91 (61.9%) | 0.292 | | Etiology | | | | | History of CNS infection | 4 (36.4%) | 16 (10.9%) | 0.022 | | History of head trauma | 0 (0%) | 12 (8.2%) | 1.000 | | Family history | 1 (9.1%) | 32 (21.8%) | 0.406 | | Febrile seizures | 1 (9.1%) | 33 (22.4%) | 0.405 | | Perinatal complications | 1 (9.1%) | 9 (6.1%) | 0.374 | | Developmental delay | 1 (9.1%) | 9 (6.1%) | 0.374 | | imaging | | | | | Normal MRI | 0/10 (0%) | 15/104 (14.4%) | 0.301 | | Hippocampal atrophy | 2/10 (20%) | 20/104 (19.2%) | 1.000 | | Hippocampal atrophy and sclerosis | 6/10 (60%) | 48/104 (46.2%) | 0.466 | | Other temporal lesion | 5 (45.5%) | 46 (31.3%) | 0.270 | | Scalp EEG | | | | | Localizing to TL | 7 (63.6%) | 81/144 (56.3%) | 0.690 | | Lateralizing | 3 (27.3%) | 34/144 (23.6%) | 0.641 | | Nonlateralizing | 1 (9.1%) | 29/144 (20.1%) | 0.615 | | SPECT localizing to TL | 2/7 (28.6%) | 63/89 (70.8%) | 0.025 | | FDG PET | | | | | Normal | 0/0 (?) | 2/15 (13.3%) | N/A | | Temporal focus | 0/0 (?) | 13/15 (86.7%) | N/A | | Intracranial electrode implantation | 6 (54.5%) | 70 (47.6%) | 0.692 | | Surgery | | | | | SAH | 2 (18.2%) | 25 (17%) | 0.839 | | ATL | 7 (63.6%) | 111 (75.5%) | 0.417 | | ATL and lesionectomy | 0 (0%) | 6 (4.1%) | 1.000 | | Lesionectomy | 2 (18.2%) | 5 (3.4%) | 0.039 | | ECOG | 0 (0%) | 4 (2.7%) | 0.610 | | Pathology | | | | | Sclerosis | 7 (63.6%) | 62 (42.2%) | 0.179 | | Cavernoma | 1 (9.1%) | 3 (2%) | 0.162 | | Glioma | 1 (9.1%) | 4 (2.7%) | 0.199 | | Ganglioglioma | 0 (0%) | 6 (4.1%) | 1.000 | | Focal cortical dysplasia | 0 (0%) | 4 (2.7%) | 0.610 | | DNET | 0 (0%) | 2 (1.4%) | 1.000 | | Gliosis | 0 (0%) | 3 (2%) | 0.572 | | Normal | 0 (0%) | 24 (16.3%) | 0.172 |
|
|
